Inventor · disambiguated record
Eldon Scott Priestley
Also filed as: PRIESTLEY ELDON SCOTT
23 granted patents·9 pending applications·101 citations·filing 2002–2024
94Inventor score
Files withBRISTOL MYERS SQUIBB CO26UNIV MONTREAL2BISTOL MYERS SQUIBB COMPANY1PRIESTLEY ELDON SCOTT1WURTZ NICHOLAS RONALD1
Top patents by PatentIndex Score
32 records- 0194US6803374B2Compounds useful for treating hepatitis C virusBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Oct 12, 2004·41 cites·15 claims
- 0293US10047103B2Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregationBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Aug 14, 2018·11 cites·22 claims
- 0392US10822343B2Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregationBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Nov 3, 2020·4 cites·15 claims
- 0492US10428077B2Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregationBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Oct 1, 2019·8 cites·9 claims
- 0590US9688695B2Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregationBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jun 27, 2017·11 cites·51 claims
- 0686US9518064B2Imidazothiadiazole and imidazopyridazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregationBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Dec 13, 2016·5 cites·18 claims
- 0786US9174974B2Macrocyclic factor VIIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Nov 3, 2015·5 cites·9 claims
- 0885US2025002497A1Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregationBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 0985US2024327390A1Substituted nitrogen containing compoundsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 1084US7456195B2Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulantsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Nov 25, 2008·6 cites·11 claims
- 1182US11932658B2Tricyclic heteroaryl-substituted quinoline and azaquinoline compounds as PAR4 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Mar 19, 2024·1 cites·19 claims
- 1282US7592331B2Macrocyclic factor VIIa inhibitors useful as anticoagulantsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Sep 22, 2009·5 cites·25 claims
- 1380US12084452B2Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregationBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Sep 10, 2024·0 cites·6 claims
- 1479US2023124468A1Substituted nitrogen containing compoundsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 1576US10501449B2Substituted nitrogen containing compoundsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Dec 10, 2019·1 cites·61 claims
- 1672USRE49700ESubstituted nitrogen containing compoundsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Oct 17, 2023·0 cites·61 claims
- 1771US10730868B2Bicyclic heteroaryl substituted compoundsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Aug 4, 2020·1 cites·14 claims
- 1870US2020339550A1Substituted nitrogen containing compoundsBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 1970US2020109135A1Substituted nitrogen containing compoundsBRISTOL MYERS SQUIBB CO·Filed 2019·Application pending·0 cites
- 2068US12037324B2Biarylmethyl heterocyclesUNIV MONTREAL·Filed 2022·Granted Jul 16, 2024·0 cites·17 claims
- 2166US8420830B2Macrocyclic factor VIIa inhibitors useful as anticoagulantsWURTZ NICHOLAS RONALD·Filed 2007·Granted Apr 16, 2013·2 cites·17 claims
- 2259US12060347B2Bicyclic heteroaryl substituted compoundsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Aug 13, 2024·0 cites·33 claims
- 2356US2019315774A1Tricyclic heteroaryl-substituted quinoline and azaquinoline compounds as par4 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Application pending·0 cites
- 2456US2009281139A1Macrocyclic factor viia inhibitors useful as anticoagulantsBRISTOL MYERS SQUIBB CO·Filed 2009·Application pending·0 cites
- 2554US11407733B2Biarylmethyl heterocyclesUNIV MONTREAL·Filed 2017·Granted Aug 9, 2022·0 cites·14 claims
- 2647US8039506B2Bicyclic lactam factor VIIa inhibitors useful as anticoagulantsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Oct 18, 2011·0 cites·16 claims
- 2747US2003134853A1Compounds useful for treating hepatitis C virusFiled 2002·Application pending·0 cites
- 2843US7622585B2Phenylglycinamide derivatives useful as anticoagulantsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Nov 24, 2009·0 cites·23 claims
- 2941US10815224B2Monocyclic heteroaryl substituted compoundsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Oct 27, 2020·0 cites·10 claims
- 3041US2019292176A1Bicyclic heteroaryl substituted compoundsBISTOL MYERS SQUIBB COMPANY·Filed 2017·Application pending·0 cites
- 3140US10723723B2Substituted bicycle heterocyclic derivatives useful as ROMK channel inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jul 28, 2020·0 cites·14 claims
- 3239US8222453B2Benzamide factor VIIa inhibitors useful as anticoagulantsPRIESTLEY ELDON SCOTT·Filed 2007·Granted Jul 17, 2012·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Eldon Scott Priestley files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →